Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 26Cyclophosphamide 24Busulfan 21Cyclosporine 20Mycophenolic Acid 19Cytarabine 16Antilymphocyte Serum 15Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 13Filgrastim 13Methotrexate 11Melphalan 10Etoposide 10Cord Blood Stem Cell Transplantation 9Methylprednisolone 8sargramostim 6Transplantation 5Idarubicin 5Thiotepa 4Flow Cytometry 4Daunorubicin 4Cytogenetic Analysis 4Immunologic Techniques 3Granulocyte Colony-Stimulating Factor 3Gemtuzumab 3tipifarnib 2merphos 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Podophyllotoxin × Classical hematology × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡